entertainment -WSS

entertainment

author：hotspot 2025-09-07 21:56:36 - browse：8677

Eli Lilly headquarters — Kristoffer Tripplaar/AP

Eventually, the luckiest companies get to deal with a very particular problem: what to do when their stock could be getting ahead of itself.

It’s a problem Eli Lilly got a little taste of Tuesday when it announced its full-year earnings. The drugmaker’s stock has more than doubled over the past 12 months due to the ever-increasing hopes for its GLP-1-based diabetes and weight loss drug, sold under the brand names Mounjaro and Zepbound. It was a big deal when Lilly became the first drug company ever to have a market value of $500 billion; it’s now sitting at a stunning $670 billion.

At first, the earnings report suggested the company had blasted through expectations again, announcing fourth-quarter 2023 sales of $9.35 billion, almost half a billion dollars above analysts’ expectations, and also announcing new data for Mounjaro in treating metabolic dysfunction-associated steatohepatitis (MASH), a form of liver disease previously called NASH. Initially, shares traded up 5%.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Can CDC director Mandy Cohen drive consensus in Washington?

leisure time

WSS

Studies point to risks of excluding people with obesity from drug trials

Argenx drug significantly slows progression of nerve disorder

Why health workers in Gaza are injured or die at high rates

STAT Summit: Michael J. Fox on progress in Parkinson's research

Congress: Eradicate hepatitis C and reduce the deficit

Hospital price transparency does save money, advocate argues

knowledge

entertainment

Wikipedia

Activists slam private health insurers over coverage restrictions

Woman gored by Bison at Yellowstone

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

STAT Summit: GSK CEO on pharma giant's new direction

Sports medicine is finally prioritizing gender equality

CEOs share strategies for surviving biotech slump

Medicare details structure of new drug price negotiation program

Care demand spikes challenge UnitedHealth’s provider arm

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Beam Therapeutics to lay off 20% of its staff, re

hotspot

Congress: Eradicate hepatitis C and reduce the deficit

STAT Summit: Biotech founders on deal

Lawmakers consider Medicare pay reforms for doctors

Congress likely to miss an opportunity to fix drug shortages issue

Does aspartame cause cancer? What new WHO guidance says

STAT Summit: How a Chicago ER doctor tackles gun violence

leisure time

hotspot

Wikipedia

explore